jueves, 13 de marzo de 2014

Citario/El dijo que...Pfizer (Ian Read)

Unless we’re respected by society, unless we’re seen as good stewards of our resources,...” 

“...then we run the risk of both losing patents and losing the ability to price our medications.” 

Strategic pricing is of utmost importance for pharmaceutical companies.

An inappropriately priced drug could undermine the intellectual property protecting the scientific advancements.  

Ian Read*, Pfizer CEO / The Economist
Publicar un comentario